Auctus Surgical

Auctus Surgical

Pre-clinical
San Jose, United StatesFounded 2015auctussurgical.com

Auctus Surgical is pioneering a non-fusion approach to pediatric scoliosis correction, focusing on technologies that allow for post-implant, non-surgical adjustments to accommodate a child's growth. The company leverages a founding team with deep experience in orthopedic implants and spinal devices, supported by a distinguished medical advisory board of leading pediatric orthopedic surgeons and neurosurgeons. Their primary technology appears to be an advancement on Vertebral Body Tethering (VBT), aiming to improve upon current fusion and non-fusion surgical options by offering greater control and fewer limitations for young patients.

Founded
2015
Focus
Medical Devices

AI Company Overview

Auctus Surgical is pioneering a non-fusion approach to pediatric scoliosis correction, focusing on technologies that allow for post-implant, non-surgical adjustments to accommodate a child's growth. The company leverages a founding team with deep experience in orthopedic implants and spinal devices, supported by a distinguished medical advisory board of leading pediatric orthopedic surgeons and neurosurgeons. Their primary technology appears to be an advancement on Vertebral Body Tethering (VBT), aiming to improve upon current fusion and non-fusion surgical options by offering greater control and fewer limitations for young patients.

Technology Platform

A platform for non-fusion scoliosis correction, centered on an advanced Vertebral Body Tethering (VBT) system that allows for dynamic, non-surgical adjustment of the implant's tension over time to guide spinal growth in children.

Funding History

1

Total raised: $2.5M

Seed$2.5MUndisclosedSep 15, 2020

Opportunities

The primary growth opportunity lies in capturing a significant share of the pediatric scoliosis surgery market by offering a superior, growth-preserving alternative to fusion.
Success could also lead to expansion into adjacent spinal deformity markets or licensing the adjustable implant technology for other orthopedic applications.

Risk Factors

Key risks include failure to obtain FDA regulatory approval, inability to demonstrate long-term clinical safety and efficacy superior to existing VBT systems, challenges in achieving surgeon adoption against entrenched competitors, and securing adequate funding to complete the costly development and approval process.

Competitive Landscape

Main competitors include large orthopedic firms (Medtronic, Johnson & Johnson, Stryker) and specialized spine companies with VBT systems (Zimmer Biomet, Globus Medical). Auctus aims to differentiate through its core feature of enabling non-surgical, post-operative adjustments to the implant, a capability not present in currently marketed devices.

Company Info

TypeTherapeutics
Founded2015
LocationSan Jose, United States
StagePre-clinical
RevenuePre-revenue

Therapeutic Areas

Pediatric OrthopedicsSpinal Disorders
SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile